ClinVar Miner

Submissions for variant NM_004187.5(KDM5C):c.2482C>T (p.Arg828Ter)

dbSNP: rs1135401800
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris RCV000496186 SCV000586761 pathogenic Syndromic X-linked intellectual disability Claes-Jensen type 2017-01-06 criteria provided, single submitter clinical testing Intellectual disability,moderate; microcephaly (-2SD); short stature
Ambry Genetics RCV000623338 SCV000741427 pathogenic Inborn genetic diseases 2016-03-25 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000496186 SCV000894493 pathogenic Syndromic X-linked intellectual disability Claes-Jensen type 2018-10-31 criteria provided, single submitter clinical testing
GeneDx RCV001553402 SCV001774263 pathogenic not provided 2023-06-06 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34536985, 28708303)
Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine RCV003126757 SCV003803859 pathogenic Developmental disorder 2022-10-31 criteria provided, single submitter clinical testing
GenomeConnect - Brain Gene Registry RCV000496186 SCV002760019 not provided Syndromic X-linked intellectual disability Claes-Jensen type no assertion provided phenotyping only Variant interpreted as Pathogenic and reported on 01-29-2021 by Lab or GTR ID Children's Hospital of Philadelphia. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.